Targeting BMI1 mitigates chemoresistance in ovarian cancer.

ABSTRACT:

SUBMITTER: Dey A 

PROVIDER: S-EPMC9485277 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature